Bought
Maintained
Sold
Other funds holding HCM
MGIM
GA
BG
CGIM
AG
UBS AM's HCM Position: Q4 2022 in Review
UBS AM sold out of HUTCHMED (HCM) in Q4 2022, closing a stake of 300,621 shares — an estimated $2.66M sold.
UBS AM first reported a position in HCM in Q4 2018 and held it in 16 quarters. The position peaked at $15.7M in Q2 2021. 84 funds tracked by Wall St. Rank hold HCM as of Q4 2022.
- UBS AM reported no remaining HUTCHMED position as of Q4 2022 after selling out during the quarter.
- UBS AM sold 300,621 HUTCHMED shares in Q4 2022, an estimated $2.66M.
- UBS AM first reported a position in HUTCHMED in Q4 2018 and held it in 16 quarters.
- UBS AM's HUTCHMED position peaked at $15.7M in Q2 2021.
- 84 funds tracked by Wall St. Rank held HUTCHMED as of Q4 2022.
Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.